APC and prostate carcinoma: A broad array of GEMMs have been developed to study the functional consequence of deregulated Wnt pathway components in prostate cancer, including the conditional deletion of Apc or constitutive activation of β-catenin specifically within the murine prostate epithelium (summarized in Table 2).